Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy
JAMA Oncology | September 30, 2019 | Volume: 6 | Issue: 3 | Pages: 367
10.1001/jamaoncol.2019.4794
| PMID 31566680